A Systems Biology Platform for Integrative Cancer Biology Research

Information

  • Research Project
  • 7803008
  • ApplicationId
    7803008
  • Core Project Number
    R44CA134175
  • Full Project Number
    2R44CA134175-02
  • Serial Number
    134175
  • FOA Number
    PA-09-080
  • Sub Project Id
  • Project Start Date
    6/10/2008 - 16 years ago
  • Project End Date
    5/31/2011 - 13 years ago
  • Program Officer Name
    EVANS, GREGORY
  • Budget Start Date
    6/10/2010 - 14 years ago
  • Budget End Date
    5/31/2011 - 13 years ago
  • Fiscal Year
    2010
  • Support Year
    2
  • Suffix
  • Award Notice Date
    6/10/2010 - 14 years ago
Organizations

A Systems Biology Platform for Integrative Cancer Biology Research

DESCRIPTION (provided by applicant): A vast ocean of "small experiments" data and OMICs datasets is being accumulated in oncology research, and none of the currently available life sciences informatics platforms is capable of a comprehensive handling and meaningful functional analysis of these data. Here we propose to build such a system, MetaMiner (Oncology) on the base of our mature data analysis platform MetaCore. The system will have a comprehensive structured database of cancer domain knowledge and a toolkit for functional analysis (ontology enrichment, interactome, network tools). MetaMiner will be integrated with CaBIG, translational medicine databases and third party software. In Phase I, we developed several novel algorithms for quantitative functional analysis of large multi-patient datasets and offered new methods for cross-analysis of cancer datasets of different type. We have also designed a framework for manual annotation of cancer pathways, assays and gene-disease causative associations. In Phase II, we will implement the algorithms into a robust "rich client" analytical platform and complete annotation of cancer data. PUBLIC HEALTH RELEVANCE: We developed novel algorithms for quantitative functional analysis and cross-analysis of datasets of different type. We designed a framework for manual annotation of cancer pathways, assays and other data. In Phase II, we will implement the algorithms into a robust "rich client" platform and complete the annotation program

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R44
  • Administering IC
    CA
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    625485
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:625485\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GENEGO, INC.
  • Organization Department
  • Organization DUNS
    113429489
  • Organization City
    ST. JOSEPH
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    490852175
  • Organization District
    UNITED STATES